Atlas Trials

A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma

Clinical trial NCT06753747 · RECRUITING

Trial details

NCT number
NCT06753747
Sponsor
West China Hospital
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Esophagus Cancer
Start date
2025-09-10
Primary completion
2027-09-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.